Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1180)
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
1,681
Price
$28.96
Total Value
$48.68K
Shares Held After
71,593
% of Holdings
2.3%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
67,608
% of Holdings
1.7%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
3,700
Price
$45.47
Total Value
$168.24K
Shares Held After
12,965
% of Holdings
22.2%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
1,300
Price
$44.44
Total Value
$57.77K
Shares Held After
16,665
% of Holdings
7.2%
Alector, Inc. (ALEC)
Berkley Neil Lindsay — CFO & Chief Business Officer
Shares
29,649
Price
$2.12
Total Value
$62.95K
Shares Held After
344,660
% of Holdings
7.9%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Jones Cecilia — Chief Financial Officer
Shares
1,573
Price
$28.96
Total Value
$45.55K
Shares Held After
49,328
% of Holdings
3.1%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Jones Cecilia — Chief Financial Officer
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
45,598
% of Holdings
2.5%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Jones Cecilia — Chief Financial Officer
Shares
1,681
Price
$28.96
Total Value
$48.68K
Shares Held After
42,785
% of Holdings
3.8%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Jones Cecilia — Chief Financial Officer
Shares
594
Price
$28.96
Total Value
$17.20K
Shares Held After
38,800
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$525.28
Total Value
$21.01K
Shares Held After
130
% of Holdings
23.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$524.04
Total Value
$83.85K
Shares Held After
170
% of Holdings
48.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
379
Price
$523.19
Total Value
$198.29K
Shares Held After
330
% of Holdings
53.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
300
Price
$522.14
Total Value
$156.64K
Shares Held After
709
% of Holdings
29.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
420
Price
$521.07
Total Value
$218.85K
Shares Held After
1,009
% of Holdings
29.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
239
Price
$520.05
Total Value
$124.29K
Shares Held After
1,429
% of Holdings
14.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
319
Price
$518.97
Total Value
$165.55K
Shares Held After
1,668
% of Holdings
16.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
598
Price
$517.85
Total Value
$309.68K
Shares Held After
1,987
% of Holdings
23.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
872
Price
$517.02
Total Value
$450.84K
Shares Held After
2,585
% of Holdings
25.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
768
Price
$515.99
Total Value
$396.28K
Shares Held After
3,457
% of Holdings
18.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,064
Price
$515.15
Total Value
$548.12K
Shares Held After
4,225
% of Holdings
20.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,042
Price
$514.02
Total Value
$535.61K
Shares Held After
5,289
% of Holdings
16.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,360
Price
$512.83
Total Value
$697.45K
Shares Held After
6,331
% of Holdings
17.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
722
Price
$511.95
Total Value
$369.63K
Shares Held After
7,691
% of Holdings
8.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
311
Price
$511.05
Total Value
$158.94K
Shares Held After
8,413
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
427
Price
$509.66
Total Value
$217.63K
Shares Held After
8,724
% of Holdings
4.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
319
Price
$508.49
Total Value
$162.21K
Shares Held After
9,151
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$507.27
Total Value
$81.16K
Shares Held After
9,470
% of Holdings
1.7%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
181
Price
$25.91
Total Value
$4.69K
Shares Held After
121,150
% of Holdings
0.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
6,106
Price
$25.16
Total Value
$153.63K
Shares Held After
121,295
% of Holdings
4.8%
Ultragenyx Pharmaceutical Inc. (RARE)
Pinion John Richard — EVP, Chief Quality Operations Officer
Shares
10,029
Price
$22.80
Total Value
$228.66K
Shares Held After
110,026
% of Holdings
8.4%
Karyopharm Therapeutics Inc. (KPTI)
Rangwala Reshma — EVP & Chief Medical Officer
Shares
5,066
Price
$9.41
Total Value
$47.67K
Shares Held After
56,739
% of Holdings
8.2%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
1,000
Price
$2.28
Total Value
$2.28K
Shares Held After
372,702
% of Holdings
0.3%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
2,000
Price
$2.00
Total Value
$4.00K
Shares Held After
627,813
% of Holdings
0.3%
Moderna, Inc. (MRNA)
Klinger Shannon Thyme — Chief Legal Officer
Shares
13,885
Price
$52.29
Total Value
$726.05K
Shares Held After
59,689
% of Holdings
18.9%
Atara Biotherapeutics, Inc. (ATRA)
Grant-Huerta Yanina — Chief Accounting Officer
Shares
100
Price
$5.08
Total Value
$508.30
Shares Held After
31,750
% of Holdings
0.3%
Atara Biotherapeutics, Inc. (ATRA)
Grant-Huerta Yanina — Chief Accounting Officer
Shares
377
Price
$5.08
Total Value
$1.92K
Shares Held After
31,850
% of Holdings
1.2%
Atara Biotherapeutics, Inc. (ATRA)
Grant-Huerta Yanina — Chief Accounting Officer
Shares
1,603
Price
$5.08
Total Value
$8.14K
Shares Held After
32,227
% of Holdings
4.7%
Atara Biotherapeutics, Inc. (ATRA)
Grant-Huerta Yanina — Chief Accounting Officer
Shares
24
Price
$5.08
Total Value
$121.85
Shares Held After
33,830
% of Holdings
0.1%
Gemini Therapeutics, Inc. (GMTX)
Savage William Jacob — Chief Medical Officer
Shares
2,986
Price
$66.41
Total Value
$198.30K
Shares Held After
85,211
% of Holdings
3.4%
Gemini Therapeutics, Inc. (GMTX)
Savage William Jacob — Chief Medical Officer
Shares
4,392
Price
$65.52
Total Value
$287.77K
Shares Held After
88,197
% of Holdings
4.7%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
34,437
Price
$9.95
Total Value
$342.65K
Shares Held After
604,639
% of Holdings
5.4%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
5,466
Price
$17.92
Total Value
$97.97K
Shares Held After
613,471
% of Holdings
0.9%
ProMIS Neurosciences Inc. (PMN)
Williams Eugene — Director
Shares
1,000
Price
$22.53
Total Value
$22.53K
Shares Held After
7,397
% of Holdings
13.5%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
100
Price
$7.06
Total Value
$706.00
Shares Held After
1,226,507
% of Holdings
0.0%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,567
Price
$6.24
Total Value
$103.38K
Shares Held After
1,226,607
% of Holdings
1.3%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
1,660
Price
$9.95
Total Value
$16.52K
Shares Held After
148,777
% of Holdings
1.1%
Stoke Therapeutics, Inc. (STOK)
Krainer Adrian R. — Director
Shares
7,229
Price
$39.66
Total Value
$286.72K
Shares Held After
316,545
% of Holdings
2.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
42
Price
$203.57
Total Value
$8.55K
Shares Held After
42,720
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
50
Price
$202.54
Total Value
$10.13K
Shares Held After
42,762
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
83
Price
$201.65
Total Value
$16.74K
Shares Held After
42,812
% of Holdings
0.2%
Showing 901–950 of 1180 transactions (page 19 of 24)